Trial intelligence / Profile preview

Rui Anning vs OxyContin for moderate-to-severe cancer pain

ChiCTR2600129724Phase 4Recruiting

Sponsor
Beijing Friendship Hospital
Start
Aug 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of oxycodone in cancer pain (2 arms), sponsored by Beijing Friendship Hospital. Primary endpoint: Effective pain relief rate at Day 7. Started Aug 2026; status: recruiting.

02

Drugs

oxycodone
03

Conditions

cancer pain

Beyond the preview

Go deeper on ChiCTR2600129724.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2600129724.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call